Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Academic Medicine : Journal of the Association of American Medical Colleges|October 31, 2008
Genetics objective structured clinical exams at the Maimonides Infants & Children's Hospital of Brooklyn, New YorkLisa Altshuler, Elizabeth Kachur, Shifra Krinshpun, et al.
Frontiers in Oncology|January 2, 2023
Post-operative ctDNA monitoring in stage I colon cancer: A case reportStephanie L Alden, Harmeet Dhani, Charuta C Palsuledesai, et al.
Case Reports in Oncology|June 15, 2022
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case ReportGeorges Azzi, Shifra Krinshpun, Antony Tin, et al.
The Oncologist|December 23, 2022
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell CarcinomaGeorges Azzi, Mehrad Tavallai, Vasily N Aushev, et al.
BMJ Open|September 25, 2021
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancerPashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2026
The landscape of genomic and socioeconomic variables in colorectal cancer patients based on genetic ancestryPreethi Srinivasan, Sara L Bristow, Fernando L Mendez, et al.
Cancer|March 4, 2023
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patientsZeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, et al.
Molecular Oncology|December 1, 2023
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumorsEkaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, et al.
JCO Precision Oncology|December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Pageof 1